Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05107427
Title Study of MRx0518 and Avelumab in Patients With Urothelial Carcinoma (AVENU)
Acronym AVENU
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors 4D pharma plc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.